Is a complete FTH research report available?

No complete published report is available for Faeth Therapeutics, Inc. (FTH) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Faeth Therapeutics, Inc. (FTH)

NASDAQ: FTH · USD

$28.3

+0.53 (+1.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FTH analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	729.3M
Net income (ttm)	-184.5M
EPS (ttm)	-$145
Shares out	25.8M
Volume	129,147
Beta	-0.26
Price target	$54.0	+90.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -184.5M
EPS (ttm): -$145
Market cap: 729.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FTH indicators

Market & fundamental data

Available fields

176

Groups with data

Currency

USD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001829802
Company name	Faeth Therapeutics, Inc.
Country	United States
Country code	US
Cusip	81728A207
Employees	29
Employees Change	14%
Employees Change Percent	93.33
Enterprise value	$527.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-12
Industry	Biotechnology
IPO Date	2021-02-04
Isin	US81728A2078
Last refreshed	2026-07-27
Market cap	$729.3M
Market cap category	Small-Cap
Price	$28.29
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.69
Sic	2834
Symbol	FTH
Website	https://www.faeththerapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.29%
FCF yield	-3.31%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-184.5M
Net Income Growth Years	3%
Profit Per Employee	$-6.4M
ROA	-95.24
Roa5y	-29.57
ROCE	-97.1
Roe5y	-51.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	298.83%
Cagr3y	4.77%
Cagr5y	-28.35%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$205.4M
Cash	$202.8M
Current Assets	$204.2M
Current Liabilities	$14.2M
Debt	$1M
Equity	$-137.3M
Interest Coverage	-5,801.3
Liabilities	$342.7M
Long Term Assets	$1.1M
Long Term Liabilities	$328.5M
Net Cash	$201.8M
Net Cash By Market Cap	$27.66
Net Cash Growth	548.25%
Tangible Book Value	$-137.3M
Tangible Book Value Per Share	$-102
WACC	2.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.39
Net Working Capital	$-11.7M
Quick ratio	14.29
Working Capital	$190M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	298.45%
200-day SMA	18.59
3Y total return	15%
50-day SMA	21.64
50-day SMA vs 200-day SMA	50over200
5Y total return	-81.11%
All Time High	530
All Time High Change	-94.66%
All Time High Date	2021-02-04
All Time Low	5
All Time Low Change	465.8%
All Time Low Date	2025-03-31
ATR	3.58
Beta	-0.26
Beta1y	1.12
Beta2y	1.83
Ch YTD	165.1
High	28.29
High52	37.9
High52 Date	2026-07-13
High52ch	-25.36%
Low	27.03
Low52	6.33
Low52 Date	2025-07-29
Low52ch	347.27%
Ma50ch	30.75%
Price vs 200-day SMA	52.18%
RSI	55.26
RSI Monthly	54.51
RSI Weekly	55.88
Sharpe ratio	1.3x
Sortino ratio	3.88
Total Return	-0.96%
Tr YTD	165.1
Tr1m	17.88%
Tr1w	9.35%
Tr3m	-13.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$56.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-4.77
Operating Income	$-185.6M
Price target	$54
Price Target Change	$90.88
Price Target Change Top	$100

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,568,347%
Float Percent	87.55%
Net Borrowing	-641,000
Shares Insiders	4.11%
Shares Institutions	8.7%
Shares Out	25,778,754
Shares Qo Q	2.67%
Shares Yo Y	0.96%
Short Float	3.94%
Short Ratio	4.98
Short Shares	3.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-37.8M
Average Volume	244,348.8x
Bv Per Share	-102.4
CAPEX	$-22,000
Ch1m	17.88
Ch1w	9.35
Ch1y	298.5
Ch3m	-13.27
Ch3y	15
Ch5y	-81.11
Ch6m	168.2
Change	1.91%
Change From Open	4.16
Close	27.76
Days Gap	-2.16
Depreciation Amortization	135,000
Dollar Volume	3,653,568.6
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-185.6M
EBITDA	$-185.5M
EPS	$-145
F Score	2
FCF	$-24.1M
FCF EV Yield	-4.57x
FCF Per Share	$-0.94
Financing CF	185,395,000
Fiscal Year End	December
Founded	1,999
Investing CF	-18,855,000
Iprfo	-94.27
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2025-06-17
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	21.53
Ma150ch	31.39%
Ma20	27.8
Ma20ch	1.76%
Net CF	142,448,000
Next Earnings Date	2026-08-07
Open	27.16
Position In Range	100
Post Close	28.29
Postmarket Change Percent	-1.48
Postmarket Price	$27.87
Ppne	982,000
Price Date	2026-07-24
Relative Volume	0.53x
Share Based Comp	13,711,000
Tr6m	168.15%
Us State	Maryland
Volume	129,147

Faeth Therapeutics, Inc. (FTH)

Coverage state: Market snapshot only — no published research

Generate the first FTH analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FTH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FTH indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FTH

Frequently asked questions